ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "chronic low back pain"

  • Abstract Number: 2165 • 2019 ACR/ARP Annual Meeting

    Stakeholder Feedback on Novel Behavioral Intervention Targeting Comorbid Chronic Back Pain and Depression in Older Adults

    Ailing Yang1, Wei Yuet 2, LaDonna Saxon 3, James LePage 3, Liana Fraenkel 4, Manney Reid 5 and Una Makris 6, 1UT Southwestern Medical Center, Dallas, 2UNT Health Science Center, Fort Worth, 3Dallas VA Medical Center and UT Southwestern Medical Center, Dallas, 4Yale School of Medicine and VA Connecticut Healthcare System, New Haven, 5Weill Cornell Medicine, New York City, 6UT Southwestern Medical Center and Dallas VA Medical Center, Dallas

    Background/Purpose: Chronic low back pain (cLBP) is the 2nd most common reason for physician visits; annual related costs exceed $100 billion and are expected to…
  • Abstract Number: 2171 • 2019 ACR/ARP Annual Meeting

    Functional Exercise for Adults with Chronic Nonspecific Low Back Pain

    Emilia Moreira1, Anamaria Jones 1, Eider Lima 1, Fabio Jennings 2 and Jamil Natour 2, 1Federal University of Sao Paulo, Sao Paulo, Sao Paulo, Brazil, 2Federal University of São Paulo, São Paulo, Brazil

    Background/Purpose: To assess the effectiveness of a functional exercise program for pain, functional capacity, general health, kinesiophobia, medication consumption and patient satisfaction in adults with chronic…
  • Abstract Number: 2766 • 2019 ACR/ARP Annual Meeting

    Patient Preferences for Attributes of Treatments for Chronic Pain Associated with Osteoarthritis Pain and Chronic Low Back Pain That Differentiate Nerve-Growth Factor Inhibitors, Nonsteroidal Anti-inflammatory Drugs, and Opioids in the United States: A Discrete-Choice Experiment

    Dennis Turk 1, Marco Boeri2, Lucy Abraham 3, Brett Hauber 4, Joanna Atkinson 3, Andrew Bushmakin 5, Joseph Cappelleri 5, Leo Russo 6, Lars Viktrup 7 and David Walsh 8, 1University of Washington, Seattle, 2RTI Health Solutions, Belfast, Northern Ireland, United Kingdom, 3Pfizer, LTD, Surrey, England, United Kingdom, 4RTI Health Solutions, Research Triangle Park, NC, 5Pfizer Inc, Groton, CT, 6Pfizer, Inc., Collegeville, PA, 7Eli Lilly and Company, Indianapolis, IN, 8Sherwood Forest Hospitals NHS Foundation Trust, Nottingham, United Kingdom

    Background/Purpose: Monoclonal antibodies that inhibit nerve growth factor (NGF-abs) may offer an alternative to current nonsteroidal anti-inflammatory drug (NSAID) and opioid treatments for osteoarthritis (OA)…
  • Abstract Number: 2794 • 2019 ACR/ARP Annual Meeting

    Predictors of Incident and Worsening Lumbar Spine Degeneration: The Johnston County Osteoarthritis Project

    Adam Goode1, Rebecca Cleveland 2, David Hu 3, Steven George 4, Virginia Byers Kraus 5, Todd Schwartz 6, Richard Gracely 7, Louis DeFrate 8, Joanne Jordan 9 and Yvonne Golightly 10, 1Duke University, Department of Orthopedic Surgery, Duke Clinical Research Institute, and Department of Population Health Sciences, Durham, NC, 2Thurston Arthritis Research Center, Chapel Hill, NC, 3Thurston Arthritis Center, University of North Carolina - Chapel Hill, Chapel Hill, NC, 4Duke University, Department of Orthopedic Surgery and Duke Clinical Research Institute, Durham, NC, 5Duke University, Department of Orthopedic Surgery, Duke Molecular Physiology Laboratory, Durham, NC, 6University of North Carolina at Chapel Hill Department of Biostatistics, Chapel Hill, NC, 7Department of Endodontics, Adams School of Dentistry, University of North Carolina, Chapel Hill, Chapel Hill, NC, 8Duke University, Department of Orthopedic Surgery, Department of Mechanical Engineering and Materials Science and Department of Biomedical Engineering, Durhham, NC, 9University of North Carolina at Chapel Hill Thurston Arthritis Research Center, Chapel Hill, NC, 10University of North Carolina at Chapel Hill Department of Epidemiology and Thurston Arthritis Research Center, Chapel Hill, NC

    Background/Purpose: Our aim was to determine whether demographics, clinical characteristics or appendicular joint osteoarthritis  predict the incidence and worsening of lumbar spine disc space narrowing…
  • Abstract Number: 330 • 2018 ACR/ARHP Annual Meeting

    The IMPACT of a Referral Algorithm for Axial Spondyloarthritis: Four Month Follow-up in Patient Reported Outcomes

    Maha Jamal1, Amber Korver2, Martijn Kuijper3, Deirisa Lopes Barreto1, Frank van den Hoogen4, Cathelijne W. Y. Appels5, Anneke Spoorenberg6, Bart Koes7, Lonneke van Hoeven8, JMW Hazes9 and Angelique EAM Weel3, 1Maasstad Hospital, Rotterdam, Netherlands, 2Erasmuc Medical Center, Rotterdam, Netherlands, 3Rheumatology, Maasstad Hospital, Rotterdam, Netherlands, 4Radboud Medical center, Nijmegen, Netherlands, 5Rheumatology, Amphia Hospital, Breda, Netherlands, 6Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 7Erasmuc Medical center, Rotterdam, Netherlands, 8Erasmus Medical center, Rotterdam, Netherlands, 9Rheumatology, Erasmus MC, Rotterdam, Netherlands

    Background/Purpose: A substantial amount of patients with chronic low back pain (CLBP) have axial spondyloarthritis (axSpA), but early recognition of these patients is difficult for…
  • Abstract Number: 2760 • 2016 ACR/ARHP Annual Meeting

    Assessment of Inflammatory Back Pain and Axial Spondyloarthritis in Brazil

    Sonia Lima1, Rita Menin2, Rejane Vieira3, Antonio Ximenes4, Valderilio Azevedo5, Claudia Suzuki6 and Flavia Heringer6, 1Faculdade de Medicina do ABC, São Paulo, Brazil, 2AV. JUSCELINO K. DE OLIVEIRA,, Famerp, Sao Jose Rio Preto, Brazil, 3Hospital Geral de Fortaleza, Fortaleza, Brazil, 4CIP- Centro Internacional de Pesquisa, Goiânia, Brazil, 5Federal University of Parana and Edumed Health Research Centerand Biotech, Curitiba, Brazil, 6AbbVie Farmacêutica Ltda., São Paulo, Brazil

    Background/Purpose: This was an observational study with retrospective (phase 1) and one-month prospective (phase 2) data collection. Medical records of subjects 18-60 years old, with…
  • Abstract Number: 705 • 2016 ACR/ARHP Annual Meeting

    Is a Positive Family History of Spondyloarthritis of Value in Patients with Chronic Back Pain? Results from Two Large Early Back Pain Cohorts

    Zineb Ez-Zaitouni1, Laure Gossec2, Inger Jorid Berg3, Robert Landewé4, Maikel van Oosterhout5, Mariagrazia Lorenzin6, Maxime Dougados7, Désirée van der Heijde8 and Floris van Gaalen1, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Paris 06 University and AP-HP, Hôpital Pitié Salpêtrière, Paris, France, 3Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 4Amsterdam Medical Center, Amsterdam, Netherlands, 5Rheumatology, Groene Hart Hospital, Gouda, Netherlands, 6Rheumatology Unit, Department of Medicine DIMED, Rheumatology Unit,University of Padova, Padova, Italy, 7Paris-Descartes University, Paris, France, 8Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: To assess whether presence of spondyloarthritis (SpA) manifestations in first- and second-degree relatives of patients with chronic back pain (CBP) is associated with higher…
  • Abstract Number: 708 • 2016 ACR/ARHP Annual Meeting

    Development of Spondyloarthritis-Features in Patients with Chronic Back Pain over a One-Year Course: Data from the Spondyloarthritis Caught Early (SPACE)-Cohort

    Zineb Ez-Zaitouni1, Miranda van Lunteren1, Pauline Bakker1, Inger Jorid Berg2, Robert Landewé3, Maikel van Oosterhout4, Augusta Ortolan5, Désirée van der Heijde1 and Floris van Gaalen1, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 3Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center, Amsterdam, Netherlands, 4Rheumatology, Groene Hart Hospital, Gouda, Netherlands, 5Rheumatology Unit, Department of Medicine DIMED, Rheumatology Unit,University of Padova, Padova, Italy

    Background/Purpose: Little is known on the development of spondyloarthritis (SpA)-features over time in patients with recent onset chronic back pain (CBP). The aim was to…
  • Abstract Number: 2586 • 2014 ACR/ARHP Annual Meeting

    Which Characteristics of Inflammatory Back Pain (CBP) Forecast the Presence of Sacroiliitis on Magnetic Resonance Imaging (MRI)? Results from the Esperanza Cohort

    Victoria Navarro-Compán1, Raquel Almodóvar González2, Azucena Hernández3, Emma Beltrán4, Eugenio De Miguel5, Robert B. M. Landewé6, Désirée van der Heijde7 and Pedro Zarco8, 1Rheumatology, University Hospital La Paz and Leiden University Medical Center, Madrid, Spain, 2Rheumatology Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain, 3Rheumatology, Hospital Virgen de la Salud, Toledo, Spain, 4University General Hospital of Valencia, Valencia, Spain, 5Rheumatology, University Hospital La Paz - IdiPaz, Madrid, Spain, 6Department of Rheumatology, Amsterdam Rheumatology Center, Amsterdam, Netherlands, 7Leiden University Medical Center, Leiden, Netherlands, 8Rheumatology Department, Fundación Hospital Alcorcon, Alcorcon, Madrid, Spain

    Background/Purpose: CBP is often the starting point for a suspicion of axSpA. In the ASAS-criteria for axial SpA either MRI of the SI-joints or HLA-B27-testing…
  • Abstract Number: 585 • 2014 ACR/ARHP Annual Meeting

    Optimism Levels Are Moderate and Similar in Patients with Axial Spondyloarthritis and Chronic Low Back Pain, and Are Related to Mental Quality of Life but Not Physical Quality of Life. a Cross Sectional Study of 277 Patients

    Sarah Kreis1,2,3, Anna Molto2,3, Florian Bailly2,3, Sabrina Dadoun2,3, Stephanie Fabre2,3,4, Christophe Hudry2, Franck Zenasni5, Sylvie Rozenberg2,3, Edouard Perthuiset4, Bruno Fautrel2,6 and Laure Gossec2,7, 1Institut de Psychologie, Laboratoire de Psychopathologie et Processus de Santé EA4057, Université Paris Descartes, Boulogne-Billancourt, France, 2Sorbonne Universités, UPMC Univ Paris 06, GRC-08, Institut Pierre Louis d’Epidémiologie et de Santé Publique, paris, France, 3Pitié-Salpêtrière Hospital, AP-HP, Rheumatology department, paris, France, 4Pontoise University Hospital, pontoise, France, 5Institut de Psychologie, Laboratoire de Psychopathologie et Processus de Santé EA4057, Université Paris Descartes, Paris, France, Boulogne-Billancourt, France, 6Rheumatology, Pitie Salpetriere Hospital, Paris, France, 7Rheumatology, Pitié-Salpêtrière Hospital, AP-HP, Paris, France

    Background/Purpose Axial Spondyloarthritis (AxSpA) and chronic low back pain (LBP) are very different chronic rheumatic diseases in terms of physiopathology and prognosis but both have…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology